Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-24T10:39:10.268Z Has data issue: false hasContentIssue false
  • English
  • Français

Inhibition and restoration of hemostasis in the young cardiac surgical patient

Published online by Cambridge University Press:  19 August 2008

David R. Jobes ,
Susan C. Nicolson  and
James M. Steven
David R. Jobes*
Affiliation:
From the Department of Anesthesiology, The Children's Hospital of Philadeiphia and The University of Pennsylvania School of Medicine, Philadelphia
Susan C. Nicolson
Affiliation:
From the Department of Anesthesiology, The Children's Hospital of Philadeiphia and The University of Pennsylvania School of Medicine, Philadelphia
James M. Steven
Affiliation:
From the Department of Anesthesiology, The Children's Hospital of Philadeiphia and The University of Pennsylvania School of Medicine, Philadelphia
*
Dr. David R. Jobes, Department of Anesthesiology, The Children's Hospital of Philadelphia, One Children's Center, Philadelphia, Pennsylvania 19104-4399, USA. Tel. 215-662-3778; Fax. 215-349-5341.
Get access Rights & Permissions [Opens in a new window]

Extract

For forty years, heparin has been used to temporarily inhibit normal coagulation so as to permit the use of extracorporeal circulation. It has proved effective in preventing gross thrombosis and has not been compromised by changes in adjunctive practices (such as profound hypothermia; circulatory arrest), new pharmacological therapies (such as anesthetics or antibiotics), devices (such as membrane oxygenators), or during use in patients at the extremes of age. Unfortunately, heparin has been and continues to be inefficient in preserving hemostatic function during cardiopulmonary bypass resulting in undesirable bleeding after surgery.

Keywords

Cardiac surgerycongenital, neonatalhemostasisextracorporeal circulationheparinprotamine
Type
World Forum for Pediatric Cardiology Symposium on Cardiopulmonary Bypass (Part 2)
Information
Cardiology in the Young , Volume 3 , Issue 4 , October 1993 , pp. 370 - 377
Copyright
Copyright © Cambridge University Press 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Manno, CS, Hedburg, KW, Kim, HC, Bunin, GR, Nicolson, SC, Jobes, DR, Schwartz, E, Norwood, WI. Comparison of the hemostatic effects of fresh whole blood, stored whole blood and components after open heart surgery in children. Blood 1991; 77:930–936.Google Scholar
2.Reynolds, LM, Nicolson, SC, Jobes, DR, Steven, JM, Manno, CS. DDAVP does not decrease bleeding after bypass in young children undergoing extensive reparative procedures. J Thorac Cardiovasc Surg 1993. [In press]CrossRefGoogle ScholarPubMed
3.Andrew, M, Paes, B, Milner, R, Johnston, M, Mitchell, L, Tollefsen, DM, Powers, P. Development of the human coagu lation system in the full-term infant. Blood 1987; 70: 165–172.CrossRefGoogle Scholar
4.Colon-Otero, G, Gilchrist, GS, Holcomb, GR, listrup, DM, Bowie, EJW. Preoperative evaluation of hemostasis in patients with heart disease. Mayo Clin Proc 1987; 62: 379–385.Google Scholar
5.Henriksson, P, Varendh, G, Lundstrom, NR. Haemostatic defects in cyanotic congenital heart disease. Br Heart J 1979; 41: 23–27.Google Scholar
6.Gill, JC, Wilson, AD, Endres-Brooks, J, Montgomery, RR. Loss of the largest von Willbrand factor multimers from the plasma of patients with congenital cardiac defects. Blood 1986; 67: 758–761.CrossRefGoogle Scholar
7.Kern, FH, Morana, NJ, Sears, JJ, Hickey, PR. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 541–546.Google Scholar
8.Bull, BS, Korpman, RA, Huse, WN, Briggs, BD. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing protocols. J Thorac Cardiovasc Surg 1975; 69: 669–674.Google Scholar
9.Bull, BS, Huse, WN, Brauer, FS, Korpman, RA. Heparin therapy during extracorporeal circulation. II. The use of a dose response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 1975; 69: 685–689.CrossRefGoogle ScholarPubMed
10.Gal, P, Ransom, JL. Neonatal thrombosis: treatment with heparin and thrombolytics. DICP, Annals of Pharmaco therapy 91; 25: 853–85.Google Scholar
11.Shah, JK, Lesley, GM, Paes, B, Ofosu, FA, Schmidt, B, Andrew, M. Thrombin inhibition is impaired in plasma of sick neo nates. Pediatr Res 1992; 31: 391–395.CrossRefGoogle Scholar
12.Manco-Johnson, MJ. Neonatal antithrombin ill deficiency. Am J Med 1989; 87: 438–499.Google Scholar
13.Schmidt, B, Mitchell, L, Ofosu, F, Andrew, M. Standard assays underestimate the concentration ofheparin in neonatal plasma. J Lab Clin Med 1988; 112: 641–643.Google Scholar
14.Jobes, DR. Unpublished data.Google Scholar
15.Vieira, A, Berry, L, Ofoso, F, Andrew, M. Heparin sensitivity and resistance in the neonate: an explanation. Thrombosis Res 1991; 63: 85–98.CrossRefGoogle ScholarPubMed
16.Gravlee, GP, Haddon, S, Rothberger, HK. Heparin dosing and monitoring for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991; 101: 499–518.Google Scholar
17.Jobes, DR.Shaffer, GW, Aitken, GL. Heparin/protamine dos ing guided by in vitro testing reduces blood loss and transfusion in cardiac surgery. Anesthesiology 1992; 77: A137.CrossRefGoogle Scholar
18.Horkay, F, Martin, P, Rajah, SM, Walker, DR. Response to heparinization in adults and children undergoing cardiac operations. Ann Thorac Surg 1992; 53: 822–826.CrossRefGoogle ScholarPubMed
19.Jobes, DR, Nicolson, SC, Epstein, R, Campbell, FW, Schwartz, AJ, Norwood, W. Hemodynamic response to rapid protamine administration in infants and children. Society of Cardiovascular Anesthesiologists proceedings of annual meeting 1986, pp 59. [Abstract]Google Scholar